Recent Results of Cetuximab Use in the Treatment of Squamous Cell Carcinoma of the Head and Neck

OncoTargets and Therapy- New Zealand

doi 10.2147/ott.s6056

Full Text

Abstract

Available in

Categories

Date

August 1, 2009

Authors

Francesco Caponigro

Publisher

Informa UK Limited

Related search

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View Beyond Cetuximab

Chemotherapy Research and Practice

English

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology: Cancer Clinical Trials

Cancer Research

English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer

English

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma

Frontiers in Oncology

Cancer Research

English

Nicotine Promotes Lymph Node Metastasis and Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma

International Journal of Oncology

Cancer Research

English

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology–Head & Neck Surgery

English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Cancer Research

English

Successful Treatment of Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck Using Pembrolizumab

Opuholi Golovy i Sei

Cancer Research

Nuclear Medicine

Otorhinolaryngology

English

Application of Molecular Targeted Therapies in the Treatment of Head and Neck Squamous Cell Carcinoma (Review)

Oncology Letters

Cancer Research

English